John W. Bateman has over 20 years of experience litigating intellectual property disputes, including serving as lead counsel for Kenyon’s clients both at trial and on appeal. He has worked on a wide variety of matters, including ones concerning patents, trademarks, copyrights and trade secrets, and has practiced before the Court of Appeals for the Federal Circuit, numerous federal district courts, the U.S. International Trade Commission (ITC), and the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences. He has been recognized by a number of legal ranking publications, including Washington, DC Super Lawyers (2014) and The Legal 500 United States (2012).
In recent years, Mr. Bateman’s litigation practice has focused on matters involving pharmaceutical products, medical devices and biotechnology, with a particular emphasis on representing generic companies in actions brought under the Hatch-Waxman Act. However, he has worked on matters involving a wide range of products, including electrical connectors, gasoline pumps, and drapery hooks.
Mr. Bateman’s practice also involves rendering opinions on infringement and validity issues regarding generic pharmaceutical products. His years of experience with Hatch-Waxman cases help him develop arguments that are more likely to prevail in litigation. In addition, he is a United States contributing author for Pharmaceutical, Biotechnology, and Chemical Inventions: World Protection and Exploitation, which was published by Oxford University Press in February 2011.
Mr. Bateman also has extensive knowledge regarding section 337 investigations at the International Trade Commission. He has litigated a number of such cases, has served on the Executive Committee of the ITC Trial Lawyers Association, and is a co-author of Unfair Competition and the ITC, a handbook on section 337 practices and procedures.